Secondary tumors after initial successful treatment of metastatic testis cancer

Current Opinion in Urology

Volumn 9, Issue 5, 1999, Pages 443-445

  Foster, Richard S ^a  

^a Department of Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CISPLATIN; ETOPOSIDE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SHORT SURVEY; TESTIS CANCER;

HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 0033398112     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199909000-00013     Document Type: Short Survey

References (6)

1. 1 Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Leewen FE, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89:1429-1439.
2. 2 Bokemeyer C, Schmoll HJ. Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 1993; 11:1703-1709.
3. 3 Van Leeuwen FE, Stiggelbout AM, van den Belt-Dvsebout AW, Noyon R, Eliel MR, van Kerkhoff EH, et al. Second cancer risk following testicular cancer: a follow up study of 1909 patients. J Clin Oncol 1993; 11:415-424.
4. 4 Nichols CR, Breeder ES, Loehrer PJ, Williams SD, Einhorn LH. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J Natl Cancer Inst 1993; 85:36-40.
5. 5 Bajoran DF, Motzer RJ, Rodriguez E, Murphy B, Bosl GJ. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst 1993; 85:60-62.
6. 6 Kollmannsberger C, Beyer J, Droz JP, Hartrick A, Hartmann JT, Biron P, et al. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J Clin Oncol 1998; 16:3386-3391.